Publication | Open Access
Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial
40
Citations
28
References
2021
Year
Both IVC and IVR are effective therapies for the treatment of ROP. Conbercept is a new option for treating ROP.
| Year | Citations | |
|---|---|---|
Page 1
Page 1